Crystalline polymorph forms of neurotrophic agent 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide (J147), and process for producing the crystalline polymorphic form are provided.

Cu(II) detection in the presence of main group heavy metal ions and d-, f- and g-element interferents relies on a colorimetric chelating complex between 3-hydroxy-5-nitrobenzaldehyde-4-hydroxybenzoylhydrazone (3-HNHBH) and Cu(II). Derivatives and entrapped forms of the probe were aligned with the methods of analysis, featuring spectrophotometric, reflectometric, lateral flow, microfluidic, lab-on-paper, positional array, dynamic array, flow cytometry and tandem stage devices. A remotely operating software capable of DFT calculations predicted the observed detection limit of 0.34 μg L.sup.−1 (<5 nM) as well as high selectivity towards copper ions in the presence of competing Zn+2 and Ni+2. The probe was readily regenerated against metal complexation by using a 0.5 M HCl solution, indicating its feasibility to be a re-usable sensor for the convenient detection of copper ions in water-organic media. The influence of metal interference, pH and solvents on the selectivity and regeneration of the ligand was incorporated in an algorithm providing decision support to the analyst via smartphone, laptop and other multimedia.

Cu(II) detection in the presence of main group heavy metal ions and d-, f- and g-element interferents relies on a colorimetric chelating complex between 3-hydroxy-5-nitrobenzaldehyde-4-hydroxybenzoylhydrazone (3-HNHBH) and Cu(II). Derivatives and entrapped forms of the probe were aligned with the methods of analysis, featuring spectrophotometric, reflectometric, lateral flow, microfluidic, lab-on-paper, positional array, dynamic array, flow cytometry and tandem stage devices. A remotely operating software capable of DFT calculations predicted the observed detection limit of 0.34 μg L.sup.−1 (<5 nM) as well as high selectivity towards copper ions in the presence of competing Zn+2 and Ni+2. The probe was readily regenerated against metal complexation by using a 0.5 M HCl solution, indicating its feasibility to be a re-usable sensor for the convenient detection of copper ions in water-organic media. The influence of metal interference, pH and solvents on the selectivity and regeneration of the ligand was incorporated in an algorithm providing decision support to the analyst via smartphone, laptop and other multimedia.

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are alkoxyl derivative compounds and pharmaceutical compositions comprising these compounds. The subject compositions are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are alkoxyl derivative compounds and pharmaceutical compositions comprising these compounds. The subject compositions are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

The present invention provides a compound having the structure: ##STR00001##
and use of the compound for inhibiting the growth of or killing

The present invention provides a compound having the structure: ##STR00001##
and use of the compound for inhibiting the growth of or killing

Provided herein are, inter alia, compounds inhibiting poly(ADP-ribose) Glycohydrolase (PARG) in a cancer cell and methods of treating cancer using compounds of the invention.

Provided herein are, inter alia, compounds inhibiting poly(ADP-ribose) Glycohydrolase (PARG) in a cancer cell and methods of treating cancer using compounds of the invention.

Crystalline polymorph forms of neurotrophic agent 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide (J147), and process for producing the crystalline polymorphic form are provided.